BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 16854482)

  • 21. The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome.
    Khoo CM; Liew CF; Chew SK; Tai ES
    Obesity (Silver Spring); 2007 Jan; 15(1):262-9. PubMed ID: 17228055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions.
    Min KB; Min JY; Paek D; Cho SI
    Pacing Clin Electrophysiol; 2008 May; 31(5):584-91. PubMed ID: 18439173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery calcification and inflammation according to various metabolic syndrome definitions.
    Narla V; Santos RD; Campbell CY; Carvalho JA; Nasir K; Budoff MJ; Blumenthal RS; Michos ED
    J Cardiometab Syndr; 2009; 4(1):33-9. PubMed ID: 19245514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
    Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
    Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
    Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
    Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
    J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Metabolic Syndrome among Malaysians using the International Diabetes Federation, National Cholesterol Education Program and Modified World Health Organization Definitions.
    Bee YT; Haresh KK; Rajibans S
    Malays J Nutr; 2008 Mar; 14(1):65-77. PubMed ID: 22691765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
    Puenpatom RA; Victor TW
    Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study.
    Koehler C; Ott P; Benke I; Hanefeld M;
    Horm Metab Res; 2007 Sep; 39(9):632-5. PubMed ID: 17846969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.
    Assmann G; Guerra R; Fox G; Cullen P; Schulte H; Willett D; Grundy SM
    Am J Cardiol; 2007 Feb; 99(4):541-8. PubMed ID: 17293200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community.
    Santos AC; Barros H
    Diab Vasc Dis Res; 2007 Dec; 4(4):320-7. PubMed ID: 18158702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS; Lee ES; Park C; Lee S; Oh SW
    Int J Obes (Lond); 2007 Mar; 31(3):528-34. PubMed ID: 16865099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.
    Dekker JM; Girman C; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
    Circulation; 2005 Aug; 112(5):666-73. PubMed ID: 16061755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
    Lin CC; Liu CS; Li TC; Chen CC; Li CI; Lin WY
    Eur J Clin Invest; 2007 Oct; 37(10):783-90. PubMed ID: 17888089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
    Timóteo A; Santos R; Lima S; Mamede A; Fernandes R; Ferreira R
    Rev Port Cardiol; 2009 Feb; 28(2):173-81. PubMed ID: 19438152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition.
    González-Ortiz M; Martínez-Abundis E; Jacques-Camarena O; Hernández-González SO; Valera-González IG; Ramos-Zavala MG
    Acta Diabetol; 2006 Nov; 43(3):84-6. PubMed ID: 17143786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.